Role of Dutasteride in Treatment of Chronic Prostatitis

• Status: Completed
• Trial end date: 2020-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

this placebo controlled study aims to evaluate the efficacy of Dutasteride in the management of Chronic prostatitis type 3.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Dutasteride

Criteria

Inclusion Criteria:

• patients aged between 40 and 70 years old, diagnosed with chronic prostatitis based on the presence of pelvic pain for ≥3 months of the preceding 6 months

Exclusion Criteria:

Patients with bacterial prostatitis

• documented site of infection along the urinary tract,

• urinary bladder tumors

• prostate cancer

• previous history of pelvic radiation or chemotherapy were excluded from our study.